A phase I/II study of paclitaxel plus cisplatin as first-line therapy for head and neck cancers: Preliminary results

1. Hitt, R.
2. Hornedo, J.
3. Colomer, R.
4. Mendiola, C.
5. Brandariz, A.
6. Sevilla, E.
7. Alvarez- Vicent, J.
8. Cortes-Funes, H.